Sickle Trait in African-American Hemodialysis Patients and Higher Erythropoiesis-Stimulating Agent Dose

African Americans require higher doses of erythropoiesis-stimulating agents (ESAs) during dialysis to manage anemia, but the influence of sickle cell trait and other hemoglobinopathy traits on anemia in dialysis patients has not been adequately evaluated. We performed a cross-sectional study of a la...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Derebail, Vimal K., Lacson, Eduardo K., Kshirsagar, Abhijit V., Key, Nigel S., Hogan, Susan L., Hakim, Raymond M., Mooney, Ann, Jani, Chinu M., Johnson, Curtis, Hu, Yichun, Falk, Ronald J., Lazarus, J. Michael
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2014
Matèries:
Clinical Epidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3968502/
https://ncbi.nlm.nih.gov/pubmed/24459231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013060575
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars